You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT JAMA
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 291 No. 13, April 7, 2004 TABLE OF CONTENTS
  JAMA
  •  Online Features
  Letters
 This Article
 •Full text
 •PDF
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citation map
 •Citing articles on HighWire
 •Citing articles on ISI (2)
 •Contact me when this article is cited
 Related Content
 •Related articles
 •Similar articles in JAMA
 Topic Collections
 •Thyroid/ Parathyroid Diseases
 •Alert me on articles by topic

Screening and Treatment for Subclinical Thyroid Disease

Since this article does not have an abstract, we have provided the first 150 words of the full text and any section headings.

To the Editor: In their Scientific Review and Clinical Applications article about subclinical thyroid disease, Dr Surks and colleagues1 stated that numerous small studies reveal subtle decreases in myocardial contractility in patients with subclinical hypothyroidism. Although the authors cited our review article2 in making this claim, they did not mention that we found diastolic dysfunction to be the most consistent cardiac abnormality in this disease. Furthermore, we reported that it tends to regress with replacement of thyroid hormone. This finding has been independently reported elsewhere.2-4

Furthermore, diastolic dysfunction has been reported not only in patients with thyroid-stimulating hormone (TSH) levels greater than 10 mU/L but also in those with TSH values between 4.5 and 10 mU/L.2-3 In contrast to this pattern with diastolic dysfunction, Surks et al reported that whereas lipid profiles are frequently abnormal when TSH levels are greater than 10 mU/L, they are seldom so in the lower . . . [Full Text of this Article]

Bernadette Biondi, MD; Gaetano Lombardi, MD
Department of Clinical and Molecular Endocrinology and Oncology

Emiliano A. Palmieri, MD
Department of Clinical Medicine and Cardiovascular Sciences
University of Naples Federico II School of Medicine
Naples, Italy


RELATED ARTICLES

Screening and Treatment for Subclinical Thyroid Disease
A. Mark Clarfield
JAMA. 2004;291(13):1562.
EXTRACT | FULL TEXT  

Screening and Treatment for Subclinical Thyroid Disease—Reply
Martin I. Surks, Nananda F. Col, Neil J. Weissman, and Gilbert H. Daniels
JAMA. 2004;291(13):1562-1563.
EXTRACT | FULL TEXT  

Subclinical Thyroid Disease: Scientific Review and Guidelines for Diagnosis and Management
Martin I. Surks, Eduardo Ortiz, Gilbert H. Daniels, Clark T. Sawin, Nananda F. Col, Rhoda H. Cobin, Jayne A. Franklyn, Jerome M. Hershman, Kenneth D. Burman, Margo A. Denke, Colum Gorman, Richard S. Cooper, and Neil J. Weissman
JAMA. 2004;291(2):228-238.
ABSTRACT | FULL TEXT  


THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

The Clinical Significance of Subclinical Thyroid Dysfunction
Biondi and Cooper
Endocr. Rev. 2008;29:76-131.
ABSTRACT | FULL TEXT  





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 2004 American Medical Association. All Rights Reserved.